Vincent Zoete obtained an engineering degree in chemistry from the ENSCL (Lille, France) in 1995, alongside a DEA  in Organic and Macromolecular Chemistry. He started his PhD in Organic Chemistry that same year at the Laboratoire de Chimie Organique et Macromoléculaire, University of Lille I. Concurrently, he obtained a Master’s degree in Drug Design in 1996 in Lille. After a one-year hiatus in 1997-1998, during which he served as a Navy Officer at the French Navy Headquarters in Paris, he completed his PhD in 1999. Following this, he moved to Strasbourg to undertake a postdoctoral fellowship in Molecular Modeling within Martin Karplus's group. During this time, he also collaborated with Enanta Pharmaceuticals (Cambridge, MA, USA). In 2003-2004, he furthered his postdoctoral research by working jointly with Markus Meuwly’s group in Basel and Martin Karplus's group in Strasbourg. In 2004, he joined the Swiss Institute of Bioinformatics (SIB) as a Research Scientist in the Molecular Modeling group of Olivier Michielin and was promoted to Associate Group Leader in 2011. In 2017, he was appointed Assistant Professor in the Department of Oncology at UNIL-CHUV and the Ludwig Institute for Cancer Research, while also serving as a Group Leader at SIB. In 2022, he achieved the rank of Associate Professor.Vincent Zoete specializes in developing innovative methods in protein engineering and computer-aided drug design, applying them to internal research projects and collaborations with academic and industrial partners. Over the course of his career, he has co-authored approximately 170 research articles and reviews, along with seven book chapters.